Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

Chemotherapy with Modified Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Metastatic Head and Neck Cancer

(2011) Jen-Tsun Lin et al.   ADVANCES IN THERAPY

Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy

(2011) Xin An et al.   CANCER

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

(2010) J. Ngeow et al.   ANNALS OF ONCOLOGY

Treatment for metastatic nasopharyngeal carcinoma

(2010) Y. Bensouda et al.   European Annals of Otorhinolaryngology-Head and Neck Diseases

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma

(2009) Xia-Yun He et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma

(2008) Daniel T. T. Chua et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Distant Metastasis of Undifferentiated Carcinoma of Nasopharyngeal Type

(2008) Yungan Tao et al.   Oncology Research and Treatment